Apnimed, Inc.

APMD

Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.

17.76 0.49 −2.68%
Market cap
$759.6M
P/E
0.9×
Fwd P/E
5.0×
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
0.00
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24
Cash and Short Term Investments
41.89 68.35
Receivables
0.96 1.12
Total current assets
45.06 73.25
Property, Plant, Equpment (Net)
0.07 0.09
Long-term assets (Other)
0.02 0.02
Total non-current assets
27.82 35.98
Total Assets
72.87 109.22
Accounts Payable
1.79 3.59
Accrued Expenses
11.03 13.56
Current Part of Capital Lease
0.25 0.22
Current Revenue (Deferred)
97.81 25.00
Total current liabilities
110.88 42.36
Long Term Debt (Total)
40.65 —
Non-current Revenue (Deferred)
15.24 45.36
Liabilities (Preferred Stock)
221.15 204.89
Non-current Liabilities (Other)
57.12 64.36
Total non-current liabilities
334.78 315.48
Total liabilities
445.66 357.84
Additional Paid In Capital
24.56 20.54
Common Stock (Net)
0.00 0.00
Retained Earnings
(397.34) (269.15)
Common Equity (Total)
(372.78) (248.61)
Shareholders Equity (Total)
(372.78) (248.61)
Shareholders Equity and Liabilities (Total)
72.87 109.22
Shares (Common)
39.82 39.82
Shareholders Equity (Tangible)
(372.78) (248.61)
Net Debt
(1.24) (68.35)
Total Debt
40.65 —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 7 Oct 2026